Growth/differentiation factor-5 induces growth arrest and apoptosis in mouse B lineage cells with modulation by Smad

Takahiro Nakahara1, Kazuhiro Tominaga, Takeyoshi Koseki

  • 1First Department of Oral and Maxillofacial Surgery, Kyushu Dental College, 803-8580, Kitakyushu, Japan.

Cellular Signalling
|December 5, 2002
PubMed

Insights

Growth/differentiation factor-5 (GDF-5) negatively impacts immune cell growth by inducing cell cycle arrest. Smad6 and Smad7 proteins inhibit this GDF-5 effect in B lineage cells.

Area of Science:

  • Cell Biology
  • Immunology
  • Molecular Biology

Background:

  • Bone morphogenetic proteins (BMPs), including growth/differentiation factor-5 (GDF-5), are key regulators of cellular processes.
  • Smad proteins are crucial intracellular signal transducers for the transforming growth factor-beta superfamily.
  • The precise mechanisms of GDF-5's negative growth effects on immune cells remain incompletely understood.

Purpose of the Study:

  • To elucidate the signaling pathway through which GDF-5 inhibits growth in immune cells.
  • To investigate the role of Smad6 and Smad7 in modulating GDF-5-mediated cellular responses.
  • To determine the impact of GDF-5 on cell cycle progression and apoptosis in B lineage cells.

Main Methods:

  • Utilized mouse B cell hybridoma HS-72 cells for experimental analysis.
  • Induced cell cycle arrest and apoptosis using GDF-5.
  • Ectopically expressed Smad6 and Smad7 to assess their inhibitory effects.
  • Monitored cell cycle phase distribution and protein expression levels (p21(CIP-1/WAF-1), retinoblastoma protein).

Main Results:

  • GDF-5 treatment induced G1 phase cell cycle arrest in HS-72 cells prior to apoptosis.
  • Ectopic expression of Smad6 and Smad7 abrogated GDF-5-induced G1 arrest.
  • Smad6 and Smad7 suppressed GDF-5-induced apoptosis in HS-72 cells.
  • The inhibitory effects of Smad6 and Smad7 were linked to the abolition of p21(CIP-1/WAF-1) expression and hypophosphorylation of retinoblastoma protein.

Conclusions:

  • Smad6 and Smad7 play a significant inhibitory role in GDF-5 signaling pathways within B lineage cells.
  • These findings highlight Smad6 and Smad7 as key negative regulators of GDF-5's effects on immune cell proliferation and survival.
  • The study provides novel insights into the molecular mechanisms governing GDF-5-induced growth inhibition in immune cells.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...